Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Mark J. Savant, M.D./San Francisco Research Institute received an FDA Warning Letter on June 26, 2025, for violations related to drug products. The letter documents two distinct violations, though the specific nature of these violations cannot be determined without access to the full warning letter text. This warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in the available metadata.